Acerus Pharmaceuticals Corporation Aktie Toronto S.E.
Aktien
A3DHGW
CA00444G4051
ASP
Pharmazeutika
Manager | Titel | Alter | Seit |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01.05.18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17.07.20 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09.09.13 |
Borys Chabursky
BRD | Director/Board Member | - | 20.12.15 |
% 1. Jan. | Kap. | |
---|---|---|
+32.36% | 695 Mrd. | |
+26.51% | 568 Mrd. | |
-4.40% | 361 Mrd. | |
+19.46% | 330 Mrd. | |
+3.50% | 283 Mrd. | |
+16.34% | 239 Mrd. | |
+6.68% | 204 Mrd. | |
-9.08% | 198 Mrd. | |
+8.62% | 168 Mrd. |